Results 221 to 230 of about 28,764 (283)

Identifying high-risk combinations of metformin during COVID-19. [PDF]

open access: yesPLoS One
Dimnjaković J   +5 more
europepmc   +1 more source

Rural Residence Is Associated With a Delayed Trend Away From Sulfonylurea Use for Treatment Intensification of Type 2 Diabetes

open access: yesDiabetes Care, 2023
   Objective: To examine the intersection between location of residence along the rural-urban continuum (metropolitan/urban/rural) and sulfonylurea dispensation records for the management of type 2 diabetes.
Lauren C Bresee, Scot H Simpson
exaly   +2 more sources

Sulfonylurea receptors and mechanism of sulfonylurea action

Experimental and Clinical Endocrinology & Diabetes, 2009
Binding of hypoglycemic sulfonylureas and their analogues to the sulfonylurea receptor in the beta-cell plasma membrane mediates closure of the ATP-sensitive K+-channel (KATP-channel) and thereby stimulation of insulin release. The sulfonylurea receptor is a member of the traffic ATPase family with two intracellular nucleotide binding folds.
U, Panten   +2 more
openaire   +2 more sources

The pharmacology of sulfonylureas

The American Journal of Medicine, 1981
In this report we review the pharmacology of the hypoglycemic sulfonylurea drugs. The early work with sulfonylureas is briefly described. The pharmacokinetics of first-generation sulfonylureas, such as tolbutamide, chlorpropamide, acetohexamide and tolazamide, are described.
T G, Skillman, J M, Feldman
openaire   +2 more sources

Sulfonylureas and the Heart

Annual Review of Medicine, 1974
Sulfonylurea drugs such as tolbutamide have been used extensively in the treatment of patients with diabetes mellitus. The recent report of the University Group Dia­ betes Program (UGDP) (1) suggested an association of tolbutamide therapy with increased incidence of cardiovascular deaths.
G S, Levey, K C, Lasseter, R F, Palmer
openaire   +2 more sources

Home - About - Disclaimer - Privacy